Universal
UVV NYSE Tobacco Financials FY2017βFY2026
Universal's revenue fell 1.3% to $2.9 billion in fiscal 2026. Its operating margin was 5.8%, down from 8.0% a year earlier. Free cash flow was $80 million, down 69.6%. It paid out $81 million in dividends and buybacks, 101% of free cash flow. The diluted share count rose 0.2%.
What Universal does
No business description yet.
- Legal name
- UNIVERSAL CORPORATION
- Fiscal year ends
- March 31, 2026
- Latest annual report
- β
- Accession Β· CIK
- 0001628280-26-039511
0000102037
Revenue and margins
Universal had $2.9B of revenue in fiscal 2026, down 1.3% on the year before.
Net income and earnings per share
From fiscal 2017 to 2026, diluted EPS grew 4.4% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $80.3M in fiscal 2026, 2.8% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Universal returned $81.3M to shareholders in fiscal 2026, 101% of free cash flow. The diluted share count rose 0.2%.
Value Universal yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β the answer depends entirely on what you put in.
Discounted cash flow
Value per share
β
Adds net cash of β$842M and divides by 25.2M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Earnings multiple
Value per share
β
Reference multiples: today 51.7x Β· peers 22.4x Β· sector 24.2x.
Balance sheet
Cash, debt and the ratios that show how comfortably Universal can carry it.
| Fiscal year end | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Cash and short-term investments | $81.6M | $64.7M | $55.6M | $260M | $62.2M |
| Debt incl. finance leases | $701M | $812M | $1.0B | $1.1B | $904M |
| Net debt / EBITDA | 2.9x | 3.1x | 3.5x | 2.8x | 3.8x |
| Debt / equity | 0.5x | 0.6x | 0.7x | 0.7x | 0.6x |
| Interest coverage | 5.8x | 3.7x | 3.4x | 2.9x | 2.3x |
| Current ratio | 3.4x | 4.1x | 3.0x | 2.9x | 3.5x |
| Quick ratio | 3.4x | 4.1x | 3.0x | 2.9x | 3.5x |
| Total assets | $2.6B | $2.6B | $2.9B | $3.0B | $2.8B |
| Total liabilities | $1.2B | $1.2B | $1.5B | $1.5B | $1.3B |
| Shareholders' equity | $1.3B | $1.4B | $1.4B | $1.5B | $1.4B |
| Net debt (β = net cash) | $620M | $748M | $979M | $813M | $842M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.5M
2 insiders
Of sales under plans
0%
$0.0M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Aug 10, 2026 | Lennart R. FreemanDirector | Sold | 1,782 | $49.82 | $0.1M | Form 4 |
| Jun 3, 2026 | Robert C SleddDirector | Sold | 2,845 | $54.13 | $0.2M | Form 4 |
| Feb 26, 2026 | Robert C SleddDirector | Sold | 1,000 | $53.95 | $0.1M | Form 4 |
| Feb 19, 2026 | Lennart R. FreemanDirector | Sold | 3,746 | $53.45 | $0.2M | Form 4 |
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY24 | FY25 | FY26 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | 3 / 9 | 4 / 9 | 5 / 9 |
| Accruals ratio | 7.0% | β7.8% | β3.4% |
| Altman Z'' | 5.98 | 5.96 | 6.26 |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| Universal UVV | $986M | β1.3% | 5.8% | 2.8% | 4.0% | 51.7x | 5 | |
| Altria MO | $124.1B | β3.1% | 42.5% | 39.0% | 39.2% | 15.6x | 7 | Compare β |
| Philip Morris International PM | $311.2B | 7.3% | 36.6% | 26.2% | 35.4% | 29.1x | 7 | Compare β |
| Cal-Maine Foods CALM | $2.9B | β31.7% | 12.0% | 11.3% | β | 51.3x | β | Compare β |
| Energizer ENR | $1.6B | 2.3% | β | 2.1% | 11.1% | β | 7 | Compare β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $2.0B | $2.0B | $2.2B | $1.9B | $2.0B | $2.1B | $2.5B | $2.7B | $2.9B | $2.9B |
| Gross profit | $371M | $357M | $393M | $339M | $368M | $397M | $438M | $509M | $524M | $473M |
| Operating income | $178M | $171M | $161M | $126M | $148M | $160M | $181M | $222M | $233M | $169M |
| Interest expense | $16.3M | $15.6M | $17.5M | $19.9M | $25.0M | $27.7M | $49.3M | $66.3M | $79.6M | $74.0M |
| Pretax income | $169M | $167M | $151M | $113M | $126M | $142M | $142M | $164M | $154M | $103M |
| Income tax | $56.7M | $50.5M | $41.2M | $35.3M | $29.4M | $38.7M | $11.7M | $31.1M | $40.9M | $46.7M |
| Net income | $106M | $106M | $104M | $71.7M | $87.4M | $86.6M | $124M | $120M | $95.0M | $32.6M |
| Diluted EPS | $0.88 | $4.14 | $4.11 | $2.86 | $3.53 | $3.47 | $4.97 | $4.78 | $3.78 | $1.30 |
| Diluted shares | 0.02B | 0.03B | 0.03B | 0.03B | 0.02B | 0.02B | 0.02B | 0.03B | 0.03B | 0.03B |
| Cash flow | ||||||||||
| Cash from operations | $250M | $81.2M | $165M | $10.9M | $220M | $44.9M | β$10.6M | β$74.6M | $327M | $129M |
| Capital expenditure | $35.6M | $34.0M | $38.8M | $35.2M | $66.2M | $53.2M | $54.7M | $66.0M | $62.6M | $48.8M |
| Free cash flow | $215M | $47.2M | $126M | β$24.3M | $154M | β$8.3M | β$65.2M | β$141M | $264M | $80.3M |
| Depreciation and amortization | $36.0M | $34.9M | $37.1M | $38.4M | $44.7M | $52.5M | $57.3M | $58.3M | $59.8M | $53.4M |
| Stock-based compensation | $6.5M | $7.6M | $8.2M | $5.6M | $6.1M | $6.2M | $8.4M | $12.1M | $8.5M | $7.1M |
| Acquisitions | $0.0M | $0.0M | $0.0M | $80.2M | $162M | $103M | $0.0M | $0.0M | $0.0M | $0.0M |
| Share buybacks | $0.0M | $21.6M | $1.4M | $33.5M | $0.0M | $3.1M | $3.4M | $4.7M | $0.0M | $0.0M |
| Dividends paid | $49.8M | $54.7M | $69.9M | $75.4M | $75.2M | $76.4M | $77.4M | $78.4M | $79.7M | $81.3M |
| Dividends and buybacks | $49.8M | $76.3M | $71.3M | $109M | $75.2M | $79.5M | $80.8M | $83.2M | $79.7M | $81.3M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $284M | $234M | $298M | $107M | $197M | $81.6M | $64.7M | $55.6M | $260M | $62.2M |
| Total debt | $429M | $415M | $424M | $447M | $620M | $701M | $812M | $1.0B | $1.1B | $904M |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Current assets | $1.6B | $1.6B | $1.6B | $1.5B | $1.6B | $1.7B | $1.8B | $2.1B | $2.2B | $2.0B |
| Current liabilities | $268M | $268M | $254M | $267M | $293M | $519M | $442M | $711M | $750M | $564M |
| Inventory | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Property and equipment, net | $317M | $324M | $303M | $315M | $350M | $345M | $351M | $366M | $373M | $373M |
| Total assets | $2.1B | $2.2B | $2.1B | $2.1B | $2.3B | $2.6B | $2.6B | $2.9B | $3.0B | $2.8B |
| Total liabilities | $797M | $783M | $753M | $832M | $994M | $1.2B | $1.2B | $1.5B | $1.5B | $1.3B |
| Shareholders' equity | $1.3B | $1.3B | $1.3B | $1.2B | $1.3B | $1.3B | $1.4B | $1.4B | $1.5B | $1.4B |
| Margins | ||||||||||
| Gross margin | 18.1% | 17.7% | 17.7% | 17.9% | 18.7% | 19.0% | 17.2% | 18.7% | 17.9% | 16.4% |
| Operating margin | 8.7% | 8.5% | 7.3% | 6.7% | 7.5% | 7.7% | 7.1% | 8.2% | 8.0% | 5.8% |
| EBITDA margin | 10.5% | 10.2% | 9.0% | 8.7% | 9.8% | 10.2% | 9.4% | 10.3% | 10.0% | 7.7% |
| Net margin | 5.2% | 5.2% | 4.7% | 3.8% | 4.5% | 4.1% | 4.9% | 4.4% | 3.3% | 1.1% |
| FCF margin | 10.5% | 2.3% | 5.7% | β1.3% | 7.9% | β0.4% | β2.6% | β5.2% | 9.0% | 2.8% |
| Returns | ||||||||||
| Return on capital | 7.8% | 7.8% | 7.6% | 5.6% | 6.7% | 6.2% | 7.9% | 7.8% | 7.2% | 4.0% |
| Return on capital employed | 9.3% | 9.1% | 8.5% | 6.8% | 7.6% | 7.8% | 8.5% | 10.0% | 10.4% | 7.6% |
| Return on equity | 7.9% | 8.0% | 7.8% | 5.6% | 6.9% | 6.5% | 9.1% | 8.4% | 6.6% | 2.3% |
| Return on assets | 4.9% | 4.9% | 4.8% | 3.4% | 3.9% | 3.5% | 4.8% | 4.3% | 3.2% | 1.1% |
| Growth | ||||||||||
| Revenue growth | β3.4% | β1.4% | 9.6% | β14.5% | 3.9% | 6.4% | 21.9% | 6.7% | 7.4% | β1.3% |
| Net income growth | β2.5% | β0.6% | β1.5% | β31.2% | 21.9% | β1.0% | 43.3% | β3.6% | β20.5% | β65.7% |
| EPS growth | β77.6% | 370.5% | β0.7% | β30.4% | 23.4% | β1.7% | 43.2% | β3.8% | β20.9% | β65.6% |
| FCF growth | 54.0% | β78.0% | 166.4% | β119.4% | β | β105.4% | β | β | β | β69.6% |
| Share count change | β14.6% | 7.3% | β0.7% | β0.9% | β1.3% | 0.5% | 0.1% | 0.4% | 0.4% | 0.2% |
| Financial health | ||||||||||
| Net debt / EBITDA | 0.7x | 0.9x | 0.6x | 2.1x | 2.2x | 2.9x | 3.1x | 3.5x | 2.8x | 3.8x |
| Debt / equity | 0.3x | 0.3x | 0.3x | 0.4x | 0.5x | 0.5x | 0.6x | 0.7x | 0.7x | 0.6x |
| Interest coverage | 11.0x | 10.9x | 9.2x | 6.4x | 5.9x | 5.8x | 3.7x | 3.4x | 2.9x | 2.3x |
| Current ratio | 5.8x | 5.9x | 6.3x | 5.5x | 5.3x | 3.4x | 4.1x | 3.0x | 2.9x | 3.5x |
| Quick ratio | 5.8x | 5.9x | 6.3x | 5.5x | 5.3x | 3.4x | 4.1x | 3.0x | 2.9x | 3.5x |
| Capital allocation | ||||||||||
| Capex / revenue | 1.7% | 1.7% | 1.8% | 1.9% | 3.4% | 2.5% | 2.1% | 2.4% | 2.1% | 1.7% |
| Stock comp / revenue | 0.3% | 0.4% | 0.4% | 0.3% | 0.3% | 0.3% | 0.3% | 0.4% | 0.3% | 0.3% |
| Payouts / FCF | 23.2% | 161.6% | 56.7% | β | 48.7% | β | β | β | 30.1% | 101.3% |
| Quality scores | ||||||||||
| Piotroski F-score | 5.0 | 6.0 | 7.0 | 4.0 | 7.0 | 3.0 | 4.0 | 3.0 | 4.0 | 5.0 |
| Altman Z'' | 7.9 | 8.0 | 8.2 | 7.4 | 6.9 | 6.1 | 6.5 | 6.0 | 6.0 | 6.3 |
| Accruals ratio | β6.6% | 1.1% | β2.8% | 2.9% | β6.0% | 1.7% | 5.2% | 7.0% | β7.8% | β3.4% |
Source: SEC EDGAR XBRL filings (CIK 0000102037). Data updated October 20, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.